Informa (LON:INF) Shares Cross Above 200 Day Moving Average – Should You Sell?

Shares of Informa plc (LON:INF) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 832.67 and traded as high as GBX 898. Informa shares last traded at GBX 894.36, with a volume of 2,943,257 shares.

Wall Street Analyst Weigh In

Several research firms have weighed in on INF. JPMorgan Chase & Co. cut their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a research note on Thursday, July 2nd. Citigroup reduced their price target on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,093.33.

Informa Stock Performance

The stock’s 50-day simple moving average is GBX 842.43 and its 200-day simple moving average is GBX 832.64. The company has a current ratio of 0.44, a quick ratio of 1.70 and a debt-to-equity ratio of 61.56. The stock has a market cap of £11.24 billion, a price-to-earnings ratio of 1,120.50, a price-to-earnings-growth ratio of 0.75 and a beta of 0.69.

Insider Buying and Selling

In other news, insider Stephen A. Carter purchased 222 shares of the stock in a transaction on Wednesday, May 20th. The stock was purchased at an average price of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Gareth Wright purchased 222 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average cost of GBX 809 per share, for a total transaction of £1,795.98. Company insiders own 0.39% of the company’s stock.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.